NasdaqGS - Delayed Quote • USD
Neurocrine Biosciences, Inc. (NBIX)
At close: 4:00 PM EDT
After hours: 5:10 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ABERNETHY MATTHEW C Chief Financial Officer | Sale | Feb 13, 2024 | 31,528 |
| BENEVICH ERIC S. Officer | Sale | Apr 15, 2024 | 40,778 |
| DELAET INGRID Officer | Sale | Apr 1, 2024 | 7,507 |
| GANO KYLE W Officer | Sale | Feb 13, 2024 | 135,166 |
| GORMAN KEVIN CHARLES Chief Executive Officer | Conversion of Exercise of derivative security | Feb 13, 2024 | 512,052 |
| LIPPOLDT DARIN M Officer | Sale | Feb 13, 2024 | 39,740 |
| MORROW GEORGE J Director | Sale | Mar 14, 2024 | -- |
| NORWALK LESLIE V Director | Sale | Feb 27, 2024 | -- |
| POPS RICHARD F Director | Sale | Mar 13, 2024 | 29,512 |
| ROBERTS EIRY WYN Officer | Sale | Feb 13, 2024 | 23,716 |
Related Tickers
ITCI Intra-Cellular Therapies, Inc.
73.26
+1.57%
ALKS Alkermes plc
24.68
+0.98%
TAK Takeda Pharmaceutical Company Limited
13.03
-0.31%
AQST Aquestive Therapeutics, Inc.
4.0700
+3.56%
IRWD Ironwood Pharmaceuticals, Inc.
7.82
-3.22%
DVAX Dynavax Technologies Corporation
11.21
+0.36%
AVDL Avadel Pharmaceuticals plc
17.81
-0.06%
RDY Dr. Reddy's Laboratories Limited
74.55
+0.72%
EVO Evotec SE
5.02
-1.57%
LNTH Lantheus Holdings, Inc.
65.56
+0.55%